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microRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation. They
were first identified in the free-living nematode Caenorhabditis elegans, where the miRNAs lin-4 and let-7
were shown to be essential for regulating correct developmental progression. The sequence of let-7 was
subsequently found to be conserved in higher organisms and changes in expression of let-7, as well as
other miRNAs, are associated with certain cancers, indicating important regulatory roles. Some miRNAs
have been shown to have essential functions, but the roles of many are currently unknown. With the
increasing availability of genome sequence data, miRNAs have now been identified from a number of
parasitic helminths, by deep sequencing of small RNA libraries and bioinformatic approaches. While
some miRNAs are widely conserved in a range of organisms, others are helminth-specific and many
are novel to each species. Here we review the potential roles of miRNAs in regulating helminth develop-
ment, in interacting with the host environment and in development of drug resistance. Use of fluores-
cently-labeled small RNAs demonstrates uptake by parasites, at least in vitro. Therefore delivery of
miRNA inhibitors or mimics has potential to alter miRNA activity, providing a useful tool for probing
the roles of miRNAs and suggesting novel routes to therapeutics for parasite control.
 2014 Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is an open
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Gene expression in specific cells and tissues or at defined devel-
opmental stages can be regulated by a number of mechanisms.
Transcription factor (TF) binding to specific promoter sites, usually
within the 50 upstream sequence, is currently the best understood
mechanism of regulating gene expression. Presence of enhancer or
suppressor DNA motifs can alter TF activity and gene expression
under certain conditions. The accessibility of promoter regions to
TF binding is also regulated by epigenetic modification of DNA or
histones, involving methylation of DNA bases and/or methylation
or acetylation of histones, resulting in changes in gene activity. Epi-
genetic control of gene expression is increasingly studied in cancer
development and stem cell differentiation (Tarayrah and Chen,
2013), and an important role for DNA methylation in egg produc-
tion and maturation of the parasitic fluke Schistosoma mansoni
has also been demonstrated (Geyer et al., 2011). This review
focuses on another level of gene control: post-transcriptional
regulation mediated by microRNAs (miRNAs). miRNAs were first
identified in Caenorhabditis elegans (Lee et al., 1993) and, with
the advent of genome sequencing, have been identified in diverse
organisms including humans, plants, viruses and parasitic
helminths. While roles for some miRNAs have been elucidated,
the functions of most are unknown. In this review we examine
zcurrent data on miRNAs in helminths and their potential roles
in regulating development, reproduction and survival within the
host. We discuss the potential of miRNAs as therapeutic targets
for parasite control and whether altered expression of specific
miRNAs may play a role in anthelmintic resistance.2. Mechanism of microRNA-mediated gene regulation
miRNAs are small non-coding RNAs of 21-25 bp in length.
C. elegans genes lin-4 and let-7 were the first miRNAs to be identi-
fied and characterized (Lee et al., 1993; Reinhart et al., 2000) and
both are heterochronic genes – genes which regulate the timing
of developmental events (Ambros and Horvitz, 1984). Worms lack-
ing lin-4 repeat developmental events that normally occur only in
the L1 stage, in subsequent stages. Loss of another C. elegans heter-
ochronic gene, lin-14, results in the opposite phenotype (Ambros
and Horvitz, 1984). LIN-14 protein levels were shown to peak at
egg hatching and decrease thereafter (Ruvkun and Giusto, 1989),
while lin-4 showed the inverse expression pattern. lin-4was cloned
and found not to encode a protein, but a small RNA and the se-
quence of lin-4 was observed to be complementary to multiple
sites in the lin-14 30 untranslated region (UTR). From this it was
concluded that lin-4 negatively regulates lin-14 post-transcription-
ally, through binding sites in the 30UTR (Lee et al., 1993; Wightman
et al., 1993), thus paving the way to examine gene regulation by
small RNAs. Subsequently, C. elegans let-7 was identified and
shown to be a miRNA that regulated another heterochronic pro-
tein-coding gene, lin-41, through binding sites located in the 30UTR
of the lin-41 transcript (Reinhart et al., 2000). Importantly, let-7 is
conserved in diverse species, establishing the importance of miR-
NAs as additional regulators of gene expression not only in worms,
but also in higher organisms.
In animals, miRNAs bind with partial complementarity to target
sites that can be present in any region of an mRNA, but are pre-
dominantly found in the 30UTR (Bartel 2009). Each miRNA can have
many target mRNAs and a single mRNA can be regulated by multi-
ple miRNAs. miRNAs are processed from long primary transcripts
(pri-miRNA) of several hundred nucleotides, by a protein complex
containing the RNase Drosha to yield precursor-miRNAs (pre-
miRNA) which are stem-loop structures of around 70 nucleotides
(Kim et al., 2009) (Fig. 1). The enzyme Dicer then cleaves thepre-miRNA, removing the loop region to form an imperfect duplex
of around 22 base pairs. One strand of the duplex (that with a
weaker base paired 50 end, referred to as the mature or guide
strand) is incorporated into the RNA-induced silencing complex
(RISC) and directs the complex to mRNA targets, resulting in trans-
lational repression and/or mRNA destabilization (Chekulaeva and
Filipowicz, 2009). For some miRNAs, the alternative strand of the
duplex (the star strand) can be functional, but is often present in
lower amounts or may be degraded. The specificity of miRNA
binding is determined predominantly by complementarity of
nucleotides 2–7 (seed sequence) of the miRNA to the target mRNA
sequence (Bartel, 2009). As discussed below, complementarity can
be used to predict potential miRNA targets.3. microRNAs in helminths
3.1. Identifying microRNAs in parasitic helminths
The increasing availability of genome sequence data for
parasitic helminths has paved the way to identify miRNA se-
quences using both computational and experimental approaches.
The conservation of some miRNA sequences across species can
be exploited to bioinformatically identify potential miRNAs. One
approach taken previously by our lab (Winter et al., 2012) used
the mature miRNA sequences present in miRBase (ftp://mir-
base.org/pub/mirbase20) (Griffiths-Jones et al., 2008) to query
available genome assemblies using BLASTN. The genomic regions
flanking hits were excised and these candidate miRNA precursor
sequences tested using RNAfold (Hofacker et al., 1994) and CID-
miRNA (Tyagi et al., 2008). A similar approach has been automated
by others and is known as MapMi (Guerra-Assunção and Enright,
2010). As well as being an effective first step in miRNA identifica-
tion, bioinformatic searching is particularly useful in identifying
miRNAs expressed at low levels, in restricted cell types or in devel-
opmental stages not readily amenable to small RNA library
preparation.
De novo identification of miRNAs is best achieved by deep
sequencing of small RNA libraries. Sequences are mapped to the
genome and other RNA classes including tRNAs, rRNAs and mRNAs
removed from the analysis. Algorithms such as miRDeep (Friedlän-
der et al., 2012) which incorporates RNAfold, score the likelihood
of sequences representing true miRNAs based on the folding ener-
gies of genomic regions around the reads, similarity of these re-
gions to miRNA hairpins and evidence of processing by Drosha
and Dicer. In addition to miRNAs, small RNA sequencing also iden-
tifies endogenous small inhibitory (si) RNAs and PIWI-interacting
RNAs (piRNAs, known as 21U RNAs in C. elegans). Each of these
classes can be identified based on their different characteristic
folding patterns, homology to coding sequence or for piRNAs, con-
served 50 motif sequence (Ruby et al., 2006; Friedlander et al.,
2009).
Small RNA sequencing projects have been carried out for a
number of helminth species (summarized in Table 1) and small
RNA data are likely to increase with additional genome sequencing
projects underway. In the absence of assembled genome sequence
for a particular species of interest, alternative approaches have
been applied to identify miRNAs. These include mapping small
RNA sequence reads to genomes of closely related species, as we
demonstrated for Brugia pahangi (Winter et al., 2012), where the
genome data from its sister species Brugia malayi were used, and
for Echinococcus granulosus (Cucher et al., 2011) where the Echino-
coccus multilocularis genome was utilized. Identification of miRNA/
miRNA⁄ duplex sequences with low RNAcofold folding energy and
a 1-2nt 30-overhang pattern, consistent with Dicer processing, has
also been used to identify novel miRNAs (Huang et al., 2010). Data
Fig. 1. microRNA biogenesis and target binding. (A) The primary miRNA transcript (pri-miRNA) is processed in the nucleus by Drosha ribonuclease. The resulting pre-miRNA
(approximately 70 nucleotides in length) is exported to the cytoplasm where it is cleaved by Dicer to form the miRNA duplex. (B) The mature strand of the miRNA duplex is
incorporated into the RNA-induced silencing complex (RISC) and directs binding to mRNA target sequences, often in the 30UTR. Binding is specified by complementarity
between the target mRNA and miRNA seed sequence (nucleotides 2–7). An example of sequence complementarity is shown in (B).
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RNA expression, conservation, evolution and function. For exam-
ple, members of the mir-36 family have been identified in Caeno-
rhabditis species (de Wit et al., 2009), Ascaris (Wang et al., 2011)
and Brugia (Poole et al, 2010; Winter et al., 2012) as well as in
platyhelminths including Schistosoma mansoni (Marco et al.,
2013) and the free-living planarian Schmidtea mediterranea
(Palakodeti et al., 2006; Friedlander et al., 2009). mir-36 family
members appear to be helminth-specific and are expressed only
in adult and embryonic stages. Deletion of the mir-36 cluster in
C. elegans results in embryonic and larval lethality, indicating an
essential role in early development (Alvarez-Saavedra and Horvitz,
2010). In Brugia, one highly conserved mir-36 family member was
identified by deep sequencing and is enriched in adult female
worms (Winter et al., 2012). Targeting this miRNA may therefore
have potential in limiting microfilariae production.
Comparative analysis has highlighted that, while some
helminth miRNAs are widely conserved across diverse organisms
and others are specific to helminths, many are novel. It is likely
that, with additional genome data, homologues of some of these
will be found in closely related helminths. C. elegans, C. remanei
and C. briggsae share approximately 90% of miRNAs (de Witet al., 2009). However, this number drops to only 27–30% when
miRNAs from the necromenic nematode Pristionchus pacificus and
gastrointestinal nematodes Haemonchus contortus and Ascaris suum
are compared to CaenorhabditismiRNAs (de Wit et al., 2009; Wang
et al., 2011; Winter et al., 2012). The diversity of miRNA sequences
may indicate rapid evolution of this family of small RNAs and could
reflect roles for novel miRNAs in the more complex lifecycles of
parasitic species and adaptation to different environments.
Comparative analysis of miRNAs identified in S. mansoni showed
a similar pattern: of 112 miRNAs identified, 12% were conserved
in other flatworms and 64% were unique to S. mansoni (Marco
et al., 2013).
Analysis of miRNAs in P. pacificus, H. contortus, Brugia and schis-
tosome species suggest that novel miRNAs can evolve by several
mechanisms including gene duplication and arm switching. The
latter results in the mature miRNA being generated from alterna-
tive arms of the precursor (50 and 30 mature miRNAs) and examples
have been found for changes in arm usage in different lifecycle
stages, suggesting functional evolution (Griffiths-Jones et al.,
2011). miRNAs can be clustered in the genome and interestingly,
clustering of some microRNAs is conserved across species, suggest-
ing functional linkage. For example, clustering of mir-2 family
Table 1
Summary of parasitic helminth species for which microRNA sequence data is
available.
Parasite species Developmental stage References
Ascaris suum Germline, zygote, embryo, L1,
L2
Wang et al.
(2011)
Male and female adults Xu et al. (2013)
Brugia malayi Mixed stage (males, females,
mf)
Poole et al. (2010)
Brugia pahangi Mixed sex adults, L3 Winter et al.
(2012)
Haemonchus contortus Mixed sex adults, L3 Winter et al.
(2012)
Trichinella spiralis Muscle stage larvae Chen et al.
(2011a)
Angiostrongylus
cantonensis
Male and female adults Chen et al.
(2011b)
Young adults Chang et al.
(2013)
Bursaphelenchus
xylophilus
Mixed stages of different
isolates
Huang et al.
(2010)
Schistosoma japonicum Mixed sex adults,
schistosomula
Huang et al.
(2009)
Cercariae, schistsomula, Cai et al. (2011)
Male and female adults Cai et al. (2013)
Eggs
S. mansoni Mixed sex adults Simoes et al.
(2011)
Male and female adults Marco et al.
(2013)
Echinococcus granulosis Protoscolex Cucher et al.
(2011)
Taenia saginata Adult worms Ai et al. (2012)
Clonorchis sinensis Adult worms Xu et al. (2010)
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et al., 2009; de Souza Gomes et al., 2011), S. mediterranea (Palakod-
eti et al., 2006) and in H. contortus (Winter et al., 2012). These
microRNAs have roles in suppressing apoptosis and in stress re-
sponses and their conserved linkage suggests selection for their
co-ordinated expression.
Detailed analysis of small RNAs during early development of
Ascaris identified some interesting features (Wang et al., 2011).
De novo synthesis of miRNAs was detected in Ascaris embryos
immediately following fertilization and during zygote maturation,
a developmental stage considered to be transcriptionally quies-
cent. These miRNAs or their precursors could not be detected in
oocytes or spermatids, suggesting that they are not of adult origin.
This is the earliest embryonic gene expression reported in any
system. Surprisingly, another class of small RNAs, piRNAs, was
not found in Ascaris nor in Brugia (Wang et al., 2011; Winter
et al., 2012), both clade III nematodes, but was identified in clade
V nematodes for which small RNA sequence is available (Caeno-
rhabditis, Haemonchus, Pristionchus). These RNAs are important in
spermatogenesis and silencing of mobile elements in the germline
and it is suggested that other small RNAs, particularly 22G- and
26G-RNAs, may carry out these key roles in Ascaris (Wang et al.,
2011)
Study of miRNAs and piRNAs in the free-living planarian S. med-
iterranea showed that these are upregulated in neoblasts, pluripo-
tent stem cells which proliferate and act as progenitor cells for
tissue regeneration (Friedlander et al., 2009). Importantly, knock-
down of the Argonaute protein Ago-2, required for miRNA and
siRNA biogenesis, led to a reduction in neoblast population and de-
fects in regeneration (Rouhana et al., 2010). Surprisingly, among
the miRNAs upregulated is let-7, which in other systems promotes
cell differentiation rather than proliferation. In planarians, let-7
may function differently or be involved in exiting the stem cell
state. Recent studies identified neoblast-like cells in adult stage S.
mansoni and it is speculated that these may contribute to thelongevity of this parasite as well as to growth modulation of
male-female pairs and tissue regeneration following drug
treatment (Collins et al., 2013). Understanding the mechanisms
regulating neoblast maintenance and differentiation and the
potential involvement of miRNAs and piRNAs may identify new
therapeutic targets to reduce parasite development and survival.
3.2. Roles of microRNAs in C. elegans
Currently the functions of only a few helminth miRNAs are
known. C. elegans miRNAs lin-4 and let-7 were identified in genetic
screens which demonstrated their essential roles in regulating
hypodermal cell fates during early larval development (Lee et al.,
1993) and the transition from L4 to adult stage (Reinhart et al.,
2000). A previously unknown miRNA, lys-6, was identified follow-
ing a genetic screen for genes regulating the asymmetrical pattern-
ing of C. elegans ASE chemoreceptors genes (Johnston and Hobert,
2003). However, even in C. elegans, determining the functions of
most miRNAs has proved challenging in the absence of obvious
phenotypes following gene knockout. This is thought to be due
to redundancy among miRNAs; approximately 60% of miRNAs
are members of a family of 2–8 genes (Ruby et al 2006). Family
members share the same seed sequence, although it is not known
whether they regulate the same target genes. In addition, some
miRNAs may function only in certain physiological or stress condi-
tions, or may act to maintain homeostasis. It has been shown that
levels of miRNAs from multiple C. elegans families are increased on
infection with pathogenic bacteria (Kudlow et al., 2012). Surpris-
ingly, reducing miRISC activity or deleting specific miRNAs en-
hanced worm survival following infection. This suggested that
miRNA activity, particularly in the intestine, functions to dampen
pathogen responses that may be detrimental to worm physiology.
This is consistent with the reduced fecundity and sterility of many
C. elegans pathogen-resistant mutants (Miyata et al., 2008).
Deletion mutants of 87 C. elegans miRNAs have been generated
and clear phenotypes reported for only a small group (Miska et al.,
2007): deletion of the mir-35-41 gene cluster (mir-36 family) re-
sulted in temperature sensitive embryonic and larval lethality,
deletion of mir-240, mir-786 cluster increased defecation cycle
lengths, while single deletion of mir-48 or mir-241 (both members
of the let-7 family) affected developmental timing. A subsequent
study examined the effects of deleting multiple members of miRNA
families (Alvarez-Saavedra and Horvitz, 2010). This identified
essential roles for mir-42-44 acting with other members of the
mir-36 family, with deletion of all resulting in a penetrant embry-
onic and larval lethal phenotype. Deletion of the mir-51 family
(mir-51-56) resulted in defects in late embryonic development,
particularly a lack of pharynx attachment, while essential roles in
locomotion, growth, egg-laying and dauer formation were identi-
fied for the mir-58 family (mir-58, 80,81,82). Members of the mir-
58 family are orthologs of Drosophila bantam, a miRNA controlling
cell proliferation and apoptosis. Re-introduction of individual C.
elegans miRNAs from transgenes was sufficient to rescue the phe-
notypes observed following loss of all family members, supporting
the idea of functional redundancy.
It was also suggested that miRNAs may function with unrelated
miRNAs or with non-miRNA genes to generate robust regulatory
networks. Brenner et al. (2010) examined the effect of loss of spe-
cific miRNAs in a genetic background with reduced levels of all
miRNAs, using a C. elegans mutant of argonuate-like 1 (alg-1), a
miRNA binding component of the silencing complex. While alg-1
mutant worms are viable, they display developmental timing de-
fects, molting defects and early adult lethality, due mainly to
reduction of let-7 family activity. In this sensitized background, en-
hanced or synthetic phenotypes were observed for 19 of 25 miRNA
mutants tested. Brenner et al. also examined combined loss of spe-
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proteins that interact with a range of developmental signaling
pathways. Combined knockdown resulted in sterile phenotypes
for 4/11 miRNAs, indicating the importance of these miRNAs in
regulating germline development.
Data on C. elegans miRNA expression, regulation and function
are increasing and the approaches used can be applied to parasitic
helminths. For some parasite miRNAs, function may be speculated
based on homology to C. elegans miRNAs, from temporal or spatial
expression data and from target prediction programs (see below).
However, narrowing down the list of the most likely targets and
testing these experimentally is a major challenge.
3.3. miRNA expression during helminth development
Small RNA library sequence read data can be used as a first
indicator of miRNA abundance in particular life-cycle stages (Kato
et al., 2009). Relative expression through development or in partic-
ular tissues can be confirmed by quantitative real-time PCR
(qRT-PCR), miRNA microarray or Northern blot analysis. Sequence
read data from the infective L3 stage and mixed adult stages of B.
pahangi and H. contortus identified a number of miRNAs differen-
tially expressed during development, while others were abun-
dantly expressed in both stages (Winter et al., 2012). The validity
of this approach was supported by expression data on homologues
of C. elegans lin-4, which showed greater read numbers in the L3
stage, and let-7, which was more abundant in adult worms, consis-
tent with expression of their C. elegans homologues.qRT-PCR
confirmed the temporal expression of selected miRNAs (Winter
et al., 2012) and a detailed pattern of miRNA expression through
development has now been obtained for B. pahangi and H. contortus
from recent microarray analyses (Winter et al., unpublished data).
Arrays were designed to include all H. contortus and BrugiamiRNAs
identified from small RNA sequencing (mapping B. pahangi small
RNA sequences to the available B. malayi genome) and computa-
tional analysis, as well as C. elegans miRNAs. Arrays were hybri-
dised with small RNAs from a number of parasite stages
including pre- and post-infective L3 larvae, L4 and adult male
and female worms. One miRNA of particular interest is Brugia
mir-5364, the expression of which increases significantly within
24 hours of transfer from the mosquito to the vertebrate host
(Winter et al., manuscript in preparation). mir-5364 is a novel
member of the let-7 family and its rapid rise suggests a possible
role in adaptation to the environment of the mammalian host. A
number of interesting target genes have been predicted bioinfor-
matically and studies are underway to experimentally test these.
Temporal expression data on Ascaris miRNAs from RNA library
read frequency and Northern blot analysis, showed good correla-
tion. Of the 97 miRNAs identified, none were abundantly expressed
throughout development (Wang et al., 2011). Rather, most Ascaris
miRNAs seem to be expressed sequentially and could be character-
ized into four groups: enriched in germline; zygote, early and mid-
dle embryo stages; late embryo and larval stages; and multiple
developmental stages.
Profiling of microRNAs through development of S. japonicum
identified a set, including mir-1 and bantam, that are significantly
down-regulated in lung-stage schistosomula compared to cerca-
riae, although their potential targets are currently unknown (Cai
et al., 2011). Analysis of small RNAs expressed in S. mansoni adult
male or female worms identified 10 female enriched and 3 male
enriched miRNAs (Marco et al., 2013). While the mir-2/mir-71
cluster is duplicated in schistosomes, the cluster located on chro-
mosome 5 (autosome) shows female-biased expression while that
on the sex chromosome does not. It was suggested that gene dupli-
cation into an autosome may overcome selection conflict on sex
chromosomes (Gallach and Betran, 2011).Examination of miRNA expression patterns at the developmen-
tal- and, where possible, tissue-specific levels may provide some
indication as to potential biological function. As miRNAs most of-
ten negatively regulate their target genes, an inverse correlation
between miRNA and mRNA expression levels may act as a filtering
step in identifying likely target genes, although it should be
remembered that miRNAs can have a modest effect on mRNA
levels. mRNA microarray and RNA seq data are available for a
number of parasitic helminths and, combined with UTR annotation
and target prediction algorithms, are valuable resources in aiding
target identification.4. What are the targets of miRNA-mediated regulation?
4.1. Identification of miRNA target transcripts
Identification of biologically relevant targets is key to under-
standing the functions of miRNAs. A number of computational tar-
get prediction tools are available and are often used as a first step
in target identification. These score the interaction of a miRNA se-
quence with potential binding sites, usually in the 30UTR of mRNAs.
Scoring is based on a number of features including sequence com-
plementarity between the miRNA seed sequence (nucleotides 2–7)
and the target sequence, evolutionary conservation of the
predicted miRNA binding sites, free energy of the miRNA–mRNA
heteroduplex, stability of the surrounding mRNA and location of
binding sites, with positioning near the start or end of the 30UTR
considered favorable. TargetScan, PicTar, PITA, miRanda and mir-
WIP are some of the programs widely used, with each having
slightly different scoring criteria (reviewed in Thomas et al.
2010). The mirWIP algorithm was developed from verified
miRNA-mRNA relationships in immunoprecipitation studies in C.
elegans (Hammell et al., 2008) and therefore includes experimental
refinement. While these programs are available for searching
mRNAs of humans and several model organisms, including
C. elegans, they are not yet available for parasitic species. However,
using annotated genome data, it is possible to apply these
algorithms to predict parasite miRNA targets. We have used this
approach to identify potential targets of Brugia miRNAs (Winter
et al. in preparation), exploiting the genome data available for sev-
eral filarial nematode species (Ghedin et al., 2007; Godel et al.,
2012; Desjardins et al., 2013).
Experimental identification of miRNA-mRNA interactions with
components of the miRISC is increasingly used to identify in vivo
target genes. Proteins, such as ALG (Argonaute-Like Gene) or AIN
(ALG-1 INteracting protein) tagged with GFP can be expressed in
C. elegans and immunoprecipitated from miRISC using anti-GFP
antibody. mRNAs and miRNAs extracted from the precipitates are
then sequenced or analyzed by microarray to identify enrichment
in specific developmental stages (Zhang et al., 2009). A variation of
this method has been developed, referred to as high throughput
sequencing by cross-linking and immunoprecipitation (HITS-CLIP),
in which UV irradiation is used to cross-link miRNA-mRNAs to RISC
proteins. Unbound mRNAs are trimmed with nuclease and bound
complexes immunoprecipitated with antibody to RISC compo-
nents. Protected fragments are PCR amplified and sequenced to
identify the specific miRNA binding regions in precipitated mRNAs.
This method has been used to identify Argonaute binding sites in
mammalian tissues (Licatalosi et al., 2008) and has been adapted
for C. elegans (Zisoulis et al., 2010). In the absence of transfection
methods and use of GFP pulldowns, immunoprecipitation ap-
proaches can be adapted to identify miRNA-mRNA interactions in
parasitic helminths using antibodies to specific miRISC proteins.
We are currently developing this approach to identify miRNA–
mRNA interactions in H. contortus (Marks et al., unpublished data).
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can be tested using reporter assays,measuring the level of luciferase
or GFP expression in cells over-expressing a specificmiRNA of inter-
est. Commonly, the 30UTR sequence is cloned downstream of the
reporter gene and miRNA interaction(s) monitored by a decrease
in reporter activity. Candidate binding sites can be deleted or mu-
tated and restorationof reporter levels examined. This canbe carried
out in cell culture or for nematode miRNA–mRNA interactions, in
transgenic C. elegans. Reporter gene analysis was used to confirm
interaction of C. elegans let-7 with the 30UTR of Ce-lin-41, resulting
in a decrease in lac-Z reporter activity (Reinhart et al., 2000).
4.2. Could parasitic helminth miRNAs regulate host genes?
miRNA target gene analyses has focused predominantly on po-
tential targets within the same organism or tissue. However miR-
NAs of pathogens may also have effects on host mRNA
expression and be important in regulating host-parasite interac-
tions. This has been demonstrated for viral miRNAs, particularly
from human cytomegalovirus (HCMV), and may also be true of par-
asite miRNAs. Several HCMV miRNAs are important in the estab-
lishment and maintenance of viral infection by modulating host
genes involved in cell cycle control (Grey et al., 2010) and in natu-
ral killer cell function (Stern-Ginossar et al., 2007).
The importance of miRNAs in modulating mammalian immune
cell development and activity are increasingly understood (David-
son-Moncada et al., 2010). For example, the miRNA signature of T
regulatory (Treg) cells has been characterized and among the miR-
NAs expressed are mir-21 and mir-31, which have opposing effects
on the Treg TF FOXP3 (Rouas et al., 2009). In both B and T cells,mir-
155 is an important regulator and loss of mir-155 can result in in-
creased propensity for Th2 rather than Th1 responses (Rodriguez
et al., 2007). In macrophages and monocytes, mir-155 expression
increases on stimulation with LPS and was shown to positively reg-
ulate inflammatory responses (Tili et al., 2007). Supporting a pos-
sible role for pathogen miRNAs in modulating host immune
function, recent work showed that small RNAs from a common
plant fungus, Botrytis cinerea, can silence genes involved in plant
immunity (Weiberg et al., 2013). The fungal small RNAs bind to
plant Argonaute proteins and mediate silencing, particularly of
mitogen-activated protein kinase genes, to suppress immunity.
An important finding from studies of helminth miRNAs is that
many are novel and not conserved in C. elegans or other organisms.
This may reflect the complex life-cycles of parasitic species, such as
their ability to adapt to different temperatures and environments
and longer developmental times compared to C. elegans. Interest-
ingly, microarray analysis of H. contortus and B. pahangi miRNAs
indicates enrichment of novel miRNAs in the adult stage. While
these could be involved in mating and reproduction, we speculate
that some may act to regulate host genes to enable parasite devel-
opment and survival within the host environment. The ability of
parasitic helminths to suppress host immune responses is well
documented (Hewitson et al., 2009) leading to interest in their
use as therapeutics for autoimmune conditions such as inflamma-
tory bowel disease, asthma and rheumatoid arthritis (Harnett et al.,
2010; Navarro et al., 2013; Weinstock and Elliott, 2013). Protein
and glycan components of helminth excretory-secretory (ES) prod-
ucts have been studied as potential sources of immunoregulatory
factors. Could miRNAs present in ES or released from dying worms
also have evolved to modulate host responses to infection?
Surprisingly, miRNAs are extremely stable when released from
cells and canbe readilydetected in serum, leading to their use as bio-
markers for particular disease conditions including tissue injury and
cancer (Brase et al., 2010). Recentworkhas also demonstrated that S.
mansoni-derived miRNAs in human serum have potential as bio-
markers of infection (Hoy et al., 2014). The stability of extracellularmiRNAs is thought to be due to their releasewithinmicrovesicles or
exosomes or by complexing with proteins, including the argonaute
protein Ago-2, protecting them from RNase digestion (reviewed in
Hoy and Buck (2012)). We have identified several miRNAs from
in vitro ES material of H. contortus adult worms (Gu et al., unpub-
lished data). One miRNA of particular interest, Hco-mir-5352, is
upregulated inadultwormscompared to larval stages and, fromcur-
rent data, homologous sequences are present only in nematodes
infecting the gastrointestinal tract (Winter et al., 2012). The T cell
activationmarker CD69was identified as the highest scoring poten-
tial host target ofHco-mir-5352 and studies are currently underway
to test for interaction between Hco-mir-5352 and CD69 30UTR and
any effects of this miRNA on immune cell activation and differenti-
ation. This is potentially important for identifying novel mecha-
nisms by which helminths may manipulate the host environment
to aid survival, as well as identifying novel intervention strategies.5. miRNAs as potential therapeutic targets
5.1. Development of miRNA inhibitors and mimics
Levels of many miRNAs, including let-7, as well as RISC activity,
are in general decreased in many cancer cell lines and tumours.
miRNAs are therefore receiving increasing attention as potential
therapeutic targets and prognostic markers for cancer treatment.
As a result, there has been significant progress made in recent
years in the design and effective delivery of miRNA inhibitors
and mimics. Where available, genetic knockouts, with loss of spe-
cific miRNAs or RISC components, or use of miRNA sponges (Ebert
and Sharp, 2010) can also be used to determine effects of miRNA
depletion. miRNA inhibitors, or anti-miRs, are modified anti-sense
oligonucleotides with reverse complementary sequence to the ma-
ture endogenous miRNA to be inhibited. Anti-miRs form a duplex
with the endogenous miRNA, leading to it being unable to bind
to the cellular mRNA target (reviewed in van Rooij et al., 2012).
miRNA inhibitors can be modified to increase resistance to nucle-
ase digestion and enhance uptake into cells. For example, inclusion
of 20-O-methyl (OMe) group modifications, use of locked nucleic
acids (LNA) with bridged 20oxygen and 40 carbon ribose moieties,
or introduction of phosphorothioate rather than phosphodiester
linkages between nucleotides, all enhance the stability of anti-
miRs. Modifications are more limited with miRNA mimics, which
are RNA duplex molecules, as the guide strand has to be identical
to the miRNA of interest and function in the RISC. Inhibition of
miRNA function was first demonstrated in C. elegans following
injection of a 20-O-methyl oligonucleotide complementary to let-
7 into larval stages, resulting in the characteristic let-7 adult lethal
phenotype (Hutvagner et al., 2004). Using fluorescently-labeled
small RNAs, we have observed significant uptake following soaking
of B. pahangi larvae and adult stages, suggesting that miRNA
inhibition or mimickry is feasible in parasitic helminths (Fig. 2
and Winter et al., manuscript in preparation).
Currently, one LNA-based miRNA inhibitor (miravirsen) is in
human clinical trials. This is an inhibitor of mammalian mir-122,
a liver-specific miRNA which, as well as being important for liver
function, binds to the hepatitis C virus RNA genome and is required
for HCV replication (Jopling et al., 2005). In human patients suffer-
ing from chronic HCV, miravirsen significantly reduced viral load,
demonstrating the effectiveness of anti-miRs as therapeutics (Jans-
sen et al., 2013).5.2. Inhibition of miRNA-mediated pathway regulation
miRNAs are often considered to be fine tuners of gene expres-
sion. However as demonstrated by loss of let-7 or lin-4, specific
Fig. 2. In vitro uptake of fluorescently-labeled siRNA by Brugia pahangi. 100 mosquito-derived L3 stage larvae (A and B) or 1 adult female worm (C and D) were incubated in
0.5 ml (for L3s) or 1 ml (for adults) of RPMI 1640/5% foetal calf serum/1% glucose at 37 C/5% CO2, in the presence or absence of 0.5 lM Cy3-labeled siRNA (Ambion). After
48 h, parasites were washed three times in 1 ml PBS/0.1% Tween and pipetted (L3s) or picked (adults) onto a 2% agarose pad on microscope slides and viewed by fluorescent
microscopy (A and C) or under bright field (B and D) at 10 magnification. Images were collected using an Axioskop 2 Plus microscope (Zeiss), ORCA-ER digital camera
(Hamamatsu) and Openlab (Improvision) software. No fluorescence was observed in the absence of Cy3-labeled siRNA. Scale bar = 100 lm.
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plained by the relative levels of a miRNA and target mRNA and
the strength of their interaction, resulting in a molecular titration
effect. For some target genes, the protein product functions only
above a threshold level. If target abundance increases towards
the threshold, this has the effect of titrating away the miRNAs
available for binding, thus switching from gene repression to acti-
vation (Mukherji et al., 2011). miRNAs can act as master regulators
of developmental transitions and responses to environmental
changes/stresses, making them suitable control targets. Signaling
molecules and transcription factors are particularly sensitive to
changes in concentration and, as well as regulating expression of
miRNAs, some TFs are also targeted by miRNAs (Leung and Sharp,
2010). Experimental and computational prediction analysis
showed that TF-miRNA feedback loops occur more frequently than
expected by chance (Martinez et al., 2008). Immunoprecipitation
studies in C. elegans also identified enrichment for receptors, ki-
nases and ion channels among the target mRNAs in the RISC com-
plex (Zhang et al 2009). The important roles that these dominant
miRNA targets play in helminth development suggest that changes
to their regulation via miRNA inhibitors or mimics is likely to be
detrimental.
AlthoughmiRNAs frequently exert only modest effects on target
mRNA levels (average of 2-fold decrease), because they often reg-
ulate many genes functioning together in the same pathway or
protein complex, their effect can be amplified. In addition, the ef-
fect of miRNAs on target gene level can be much greater in specific
cells where the abundance of some miRNAs is high. With increas-
ing data on temporal miRNA expression, as well as identification of
many helminth-specific miRNAs, we can begin to test inhibitors
and mimics as novel therapeutics. Will inhibiting parasite miRNAs
upregulated on host infection, such as Bpa-mir-5364, or in adult
worms limit parasite survival and reproduction? Not only are miR-
NAs potentially valid targets, but understanding the overall effectsof miRNAs by characterizing their mRNA targets and their tempo-
ral and spatial expression, should identify co-ordinated pathways
and networks required for developmental transitions or responses
to stresses, which may themselves be targets for parasite control.5.3. Involvement of host miRNAs in parasitic infections
Not only is understanding roles of parasite miRNAs important
to infection control, but studying host miRNAs may also lead to no-
vel intervention strategies. Characterizing changes in host cell
miRNA profile following parasite infection may elucidate triggers
and mechanisms regulating host immunity, pathology and inflam-
mation as well as parasite-induced suppression. There is increasing
evidence that miRNAs can regulate Toll-like receptor (TLR) signal-
ing molecules, such as AP-1 and NFk-b, as well as TLR expression. It
is speculated that miRNAs may provide a link between innate and
adaptive immune pathways (reviewed in O0Neill et al., 2011) and
are therefore relevant to understanding regulation of host immu-
nity. A number of studies have examined changes in host miRNA
levels following infection to identify parasite-induced changes
and regulation of host responses. For example, infection of leuko-
cytes with the transforming parasite Theileria results in an increase
in host mir-155 which, via TFs AP-1 and c-Jun, acts to maintain the
cell hyperproliferation state and parasite survival (Marsolier et al.,
2013). Inhibition of mir-155 or AP-1 reverses parasite-induced
transformation. Changes in miRNA expression also occur in host
macrophages following implantation of B. malayi adult worms into
the peritoneal cavity and this has been shown to regulate alterna-
tive macrophage proliferation (Rückerl et al., 2012). Recently it was
shown that invasion and induction of innate immunity in myeloid
cells by North American eastern equine encephalitis virus is
blocked by a haematopoietic-cell-specific miRNA (mir-142-3p).
This host miRNA binds to the 30 end of the viral RNA genome to
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mune response and aiding virus survival (Trobaugh et al., 2013).6. microRNAs in drug resistance
miRNA expression or activity are often altered in cancer cells
and some of these changes are also thought to be associated with
development of drug resistance. Drug treatment of cancer cells
has been shown to result in altered expression of miRNAs which
target drug metabolizing enzymes and drug transporters leading
to drug resistance (Yu, 2009). For example, gemcitabine treatment
of xenograft tumours results in decreased expression of mir-328, a
miRNA which negatively regulates the ABCG2 efflux transporter
(Pan et al., 2009). Decreased mir-328 levels therefore lead to in-
creased transporter expression and multidrug resistance.
We have speculated that the link between changes in miRNA
levels and drug resistance in cancer cells may also be a feature of
drug resistance in parasitic nematodes (Devaney et al., 2010).
Altered levels of drug targets, including ion channels and nAChR
subunits have been found in isolates of H. contortus resistant to
ivermectin (Rao et al., 2009) and in A. caninum resistant to pyrantel
(Kopp et al., 2009). Following drug selection, changes were also
found in expression level and allele frequency of ABC transporters
(Prichard and Roulet, 2007) and P-glycoproteins (Blackhall et al.,
2008). Whether these changes in gene expression are mediated
by miRNAs is currently unknown. In C. elegans, mutants of mir-1,
which negatively regulates nAChR subunits unc-29 and unc-63,
show decreased muscle sensitivity to Ach and resistance to levam-
isole (Simon et al., 2008). This is thought to result from changes in
subunit composition affecting the biogenesis or function of hetero-
multimeric receptors. Recently, we have used miRNA microarray
analysis to examine the expression profile of C. elegans strains
and H. contortus isolates resistant to ivermectin. Our initial data
have identified significant and consistent changes in expression
of three miRNAs – Cel-mir-85, Cel-mir-788 and a novel H. contortus
sequence Hco-mir-9551 (Gillan et al., unpublished data). Work is
underway to identify alterations in mRNA levels which may be
associated with these miRNA changes. Obvious targets include
drug receptors, transporters and drug metabolizing enzymes, but
the transcriptomic approach has the potential to identify novel
mechanisms of drug resistance. Alternatively, the observed
changes in miRNA expression levels may be a consequence of other
changes associated with resistance. These miRNAs may also prove
to be valuable and sensitive markers of anthelmintic resistance.7. Conclusion
microRNAs of parasitic helminths are receiving increasing
attention as novel regulators of development, sex differentiation,
drug resistance and host-parasite interactions. The important and
varied roles of miRNAs identify these as valid targets of interven-
tion strategies. With genome sequence data available for more par-
asite species, miRNA identification and understanding of miRNA
evolution and function will increase. Which miRNAs are conserved
across species, which are specific to particular parasite clades or to
modes of transmission or location within the host? Improved gen-
ome assembly/annotation together with comparative analyses will
also aid target gene predictions through identification of conserved
miRNA binding sites. Parasite miRNAs may also regulate host tar-
get genes and there is increasing evidence that pathogens exploit
host miRNAs to aid replication and survival. This has been demon-
strated for HCV, which relies on hostmir-122 in liver cells, Theileria,
which alters leukocyte mir-155 levels, and equine encephalitis
virus where cell tropism seems to be mediated by a host miRNA.
It will be important to examine effects of helminth miRNAs on bothparasite and host gene expression, any parasite-induced changes in
host miRNA levels and whether host miRNA expression could also
influence helminth tropism. This has potential to lead to therapeu-
tics targeting parasite pathways as well as altering host-parasite
interactions that influence parasite survival.
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